Initial Invasive or Conservative Strategy for Stable Coronary Disease (2020)
- Authors:
- Autor USP: HUEB, WHADY ARMINDO - FM
- Unidade: FM
- DOI: 10.1056/NEJMoa1915922
- Subjects: QUALIDADE DE VIDA; REVASCULARIZAÇÃO MIOCÁRDICA; ISQUEMIA MIOCÁRDICA; DOENÇAS CARDIOVASCULARES; CATETERISMO CARDÍACO; INFERÊNCIA BAYESIANA; ANGINA INSTÁVEL
- Agências de fomento:
- Clinical and Translational Science Awards from the National Center for Advancing Translational Sciences [11UL1 TR001445, UL1 TR002243]
- AstraZeneca PharmaceuticalsAstraZeneca
- Arbor Pharmaceuticals
- National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL105907, U01HL105462, U01HL105561, U01HL105565]
- Language: Inglês
- Imprenta:
- Source:
- Título: New england journal of medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 382, n. 15, p. 1395-1407, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MARON, David J et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. New england journal of medicine, v. 382, n. 15, p. 1395-1407, 2020Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1915922. Acesso em: 22 jan. 2026. -
APA
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O'brien, S. M., Boden, W. E., et al. (2020). Initial Invasive or Conservative Strategy for Stable Coronary Disease. New england journal of medicine, 382( 15), 1395-1407. doi:10.1056/NEJMoa1915922 -
NLM
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'brien SM, Boden WE, Chaitman BR, Senior R, Lopez-sendon J, Hueb WA. Initial Invasive or Conservative Strategy for Stable Coronary Disease [Internet]. New england journal of medicine. 2020 ; 382( 15): 1395-1407.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1056/NEJMoa1915922 -
Vancouver
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'brien SM, Boden WE, Chaitman BR, Senior R, Lopez-sendon J, Hueb WA. Initial Invasive or Conservative Strategy for Stable Coronary Disease [Internet]. New england journal of medicine. 2020 ; 382( 15): 1395-1407.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1056/NEJMoa1915922 - Long-term survival following multivessel revascularization in patients with diabetes The FREEDOM Follow-On Study: the FREEDOM follow-on study
- Grandes estudos comparativos e randomizados entre os tratamentos clínico, cirúrgico ou percutâneo
- Propedêutica cardiovascular
- Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease
- Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
- Estado atual do tratamento da coronariopatia crônica em pacientes diabéticos: evidências e controvérsias baseadas em ensaios clínicos
- The Effect of Age on Outcomes of Coronary Artery Bypass Surgery Compared With Balloon Angioplasty or Bare-Metal Stent Implantation Among Patients With Multivessel Coronary Disease: A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials
- SYNTAX score in patients with diabetes undergoing coronary revascularization in the FREEDOM trial
- Conservative strategy for treatment of stable coronary artery disease
- Teratoma of the mediastinum: a case report
Informações sobre o DOI: 10.1056/NEJMoa1915922 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
